UnitedHealth Group (UNH)
(Delayed Data from NYSE)
$589.14 USD
-5.18 (-0.87%)
Updated Sep 16, 2024 04:00 PM ET
After-Market: $589.50 +0.36 (0.06%) 7:58 PM ET
2-Buy of 5 2
B Value D Growth B Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$589.14 USD
-5.18 (-0.87%)
Updated Sep 16, 2024 04:00 PM ET
After-Market: $589.50 +0.36 (0.06%) 7:58 PM ET
2-Buy of 5 2
B Value D Growth B Momentum C VGM
Zacks News
UnitedHealth Group, Inc. is the largest health care services company in the world, serving over 50 million individuals in the United States as of 2019 and over 5 million internationally. The company provides a wide range of health care products and services, such as health maintenance organizations (HMOs), point of service plans (POS), preferred provider organizations (PPOs), and managed fee-for-service programs. UnitedHealth has the largest and most diverse membership base within the managed-care organization market, which gives it significant competitive advantages. It also has built its prescription drug business through OptumRx division, with the acquisition of Catamaran in 2015.
Should You Invest in the Vanguard Health Care ETF (VHT)?
by Zacks Equity Research
Sector ETF report for VHT
Q2 Earnings Season Scorecard, Economic Outlook and Analyst Reports for NVIDIA, Meta & Others
by Sheraz Mian
Today's Research Daily features the Q2 earnings season scorecard and fresh research reports on NVIDIA (NVDA), Meta (META), Amgen and others.
Stock Market News for Jul 18, 2024
by Zacks Equity Research
Wall Street ended mostly lower on Wednesday as the rotation out of high-flying megacap tech stocks weighed on the S&P 500 and Nasdaq.
Elevance Health's (ELV) Q2 Earnings Beat on Lower Benefit Expense
by Zacks Equity Research
Elevance Health's (ELV) Q2 results gain on strong product revenue growth in the Carelon business and a reduced overall expense level. Adjusted earnings are reiterated to be at a minimum of $37.20 per share in 2024.
UnitedHealth Rises on Q2 Earnings Beat: ETFs to Gain
by Sweta Killa
UnitedHealth Group (UNH) reported better-than-expected second-quarter 2024 results as it breezed past the Zacks Consensus Estimate on both earnings and revenues.
Dow ETF Surges on Index's Best Day This Year: 5 Top Stocks
by Sweta Killa
The Dow Jones Index hit a new all-time high, notching its best one-day gain since June 2023, after reclaiming the 40,000 milestone for the first time since May.
Stock Market News for Jul 17, 2024
by Zacks Equity Research
U.S. stocks closed sharply higher on Tuesday, with the Dow hitting an all-time closing high and recording its best day in more than a year after stronger-than-expected retail sales data indicated that the Federal Reserve is gearing up for rate cuts while avoiding recession.
UnitedHealth Group (UNH) Q2 Earnings Beat on Strong Optum Unit
by Zacks Equity Research
UnitedHealth Group's (UNH) second-quarter earnings continue to be supported by strong Optum and UnitedHealthcare business lines. Rising medical costs partially offset the positives.
UnitedHealth (UNH) Reports Q2 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
The headline numbers for UnitedHealth (UNH) give insight into how the company performed in the quarter ended June 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Retail Sales Came in Better Than Expected
by Zacks Equity Research
Retail Sales Came in Better Than Expected
Econ Reports, Q2 Earnings Take July Rate Cut Off the Table
by Mark Vickery
Any investors still hoping for a July rate cut based on economic prints, we can uncross our fingers now.
UnitedHealth Group (UNH) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
UnitedHealth (UNH) delivered earnings and revenue surprises of 2.26% and 0.15%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
The Zacks Analyst Blog Eli Lilly, UnitedHealth and Tile Shop
by Zacks Equity Research
Eli Lilly, UnitedHealth and Tile Shop are included in this Analyst Blog.
Q2 Earnings Season Scorecard and Analyst Reports for Microsoft, Eli Lilly & UnitedHealth
by Sheraz Mian
Today's Research Daily features a real-time update on the Q2 earnings season and new research reports on Microsoft (MSFT), Eli Lilly (LLY) and UnitedHealth (UNH), as well as a micro-cap stock Tile Shop Holdings (TTSH).
UnitedHealth (UNH) Pre-Q2 Earnings: Healthy Buy or a Wait-&-See?
by Kaibalya Pravo Dey
UnitedHealth's (UNH) second-quarter earnings are likely to have benefited from higher premiums, driven by the expansion of its commercial membership base.
Stay Ahead of the Game With UnitedHealth (UNH) Q2 Earnings: Wall Street's Insights on Key Metrics
by Zacks Equity Research
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for UnitedHealth (UNH), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended June 2024.
Will Q2 Earnings Power Dow ETFs?
by Sweta Killa
The Dow Jones is underperforming the other large-cap indices, such as the S&P 500 and Nasdaq Composite Index. Can the upcoming Q2 earnings help the index to catch up?
UnitedHealth Group (UNH) Rises Higher Than Market: Key Facts
by Zacks Equity Research
UnitedHealth Group (UNH) reachead $492.11 at the closing of the latest trading day, reflecting a +0.57% change compared to its last close.
UnitedHealth Group (UNH) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
UnitedHealth (UNH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Take the Zacks Approach to Beat the Markets: NVIDIA, Seagate, Amkor in Focus
by Santanu Roy
Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.
UnitedHealth (UNH), Amedisys Clear Merger Hurdle With Asset Sale
by Zacks Equity Research
By selling these assets, UnitedHealth (UNH) and Amedisys aim to avoid potential monopoly issues and ensure a smoother merger process.
The Zacks Analyst Blog Highlights NVIDIA, Amazon.com and UnitedHealth
by Zacks Equity Research
NVIDIA, Amazon.com and UnitedHealth are included in this Analyst Blog.
Top Research Reports for NVIDIA, Amazon.com & UnitedHealth
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including NVIDIA Corporation (NVDA), Amazon.com, Inc. (AMZN) and UnitedHealth Group Incorporated (UNH).
UnitedHealth (UNH) Stock Drops 8% YTD: Should You Hold or Fold?
by Kaibalya Pravo Dey
As commercial business improves within the industry, UnitedHealth (UNH), with its diverse portfolio of offerings, is well-positioned to capitalize on the rising demand.
UnitedHealth Group (UNH) Increases Despite Market Slip: Here's What You Need to Know
by Zacks Equity Research
In the latest trading session, UnitedHealth Group (UNH) closed at $489.98, marking a +1.53% move from the previous day.